Your browser doesn't support javascript.
loading
Zoledronate in the prevention of Paget's (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1-mediated Paget's disease of bone.
Cronin, Owen; Forsyth, Laura; Goodman, Kirsteen; Lewis, Steff C; Keerie, Catriona; Walker, Allan; Porteous, Mary; Cetnarskyj, Roseanne; Ranganath, Lakshminarayan R; Selby, Peter L; Hampson, Geeta; Chandra, Rama; Ho, Shu; Tobias, Jon H; Young-Min, Steven; McKenna, Malachi J; Crowley, Rachel K; Fraser, William D; Gennari, Luigi; Nuti, Ranuccio; Brandi, Maria Luisa; Del Pino-Montes, Javier; Devogelaer, Jean-Pierre; Durnez, Anne; Isaia, Giancarlo; Di Stefano, Marco; Guañabens, Núria; Blanch, Josep; Seibel, Markus J; Walsh, John P; Kotowicz, Mark A; Nicholson, Geoffrey C; Duncan, Emma L; Major, Gabor; Horne, Anne; Gilchrist, Nigel L; Boers, Maarten; Murray, Gordon D; Charnock, Keith; Wilkinson, Diana; Russell, R Graham G; Ralston, Stuart H.
Affiliation
  • Cronin O; Department of Rheumatology, Western General Hospital, Edinburgh, UK.
  • Forsyth L; Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, Edinburgh, UK.
  • Goodman K; Glasgow Caledonian University School of Nursing Midwifery and Community Health, Glasgow, UK.
  • Lewis SC; Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, Edinburgh, UK.
  • Keerie C; Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, Edinburgh, UK.
  • Walker A; Edinburgh Clinical Trials Unit, Usher Institute, University of Edinburgh, Edinburgh, UK.
  • Porteous M; MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
  • Cetnarskyj R; University of Dundee - Fife Campus, Kirkcaldy, UK.
  • Ranganath LR; University of Liverpool, Liverpool, UK.
  • Selby PL; University of Manchester, Manchester, UK.
  • Hampson G; Guy's and St Thomas' NHS Trust, London, UK.
  • Chandra R; King's College Hospital, London, UK.
  • Ho S; Robert Jones and Agnes Hunt Orthopaedic and District Hospital NHS Trust, Oswestry, UK.
  • Tobias JH; Musculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
  • Young-Min S; Portsmouth Hospitals NHS Trust, Portsmouth, UK.
  • McKenna MJ; University College Dublin, Dublin, Ireland.
  • Crowley RK; University College Dublin, Dublin, Ireland.
  • Fraser WD; Department of Medicine Norwich Medical School, Faculty of Medicine and Health Sciences, University of East Anglia, Norwich, UK.
  • Gennari L; University of Siena Faculty of Medicine and Surgery, Siena, Italy.
  • Nuti R; University of Siena Faculty of Medicine and Surgery, Siena, Italy.
  • Brandi ML; University Hospital Careggi, Firenze, Italy.
  • Del Pino-Montes J; University Hospital of Salamanca, Salamanca, Spain.
  • Devogelaer JP; Cliniques Universitaires Saint-Luc, Bruxelles, Belgium.
  • Durnez A; Rheumatology, Cliniques Universitaires Saint-Luc, Bruxelles, Belgium.
  • Isaia G; Algemeen Ziekenhuis Jan Portaels, Vilvoorde, Belgium.
  • Di Stefano M; Università degli Studi di Torino, Torino, Piemonte, Italy.
  • Guañabens N; Università degli Studi di Torino, Torino, Piemonte, Italy.
  • Blanch J; Rheumatology Department, Hospital Clinic, IDIBAPS, CIBERehd, University of Barcelona, Barcelona, Spain.
  • Seibel MJ; Hospital del Mar, Barcelona, Catalunya, Spain.
  • Walsh JP; Concord Repatriation General Hospital, Sydney, New South Wales, Australia.
  • Kotowicz MA; Bone Research Program, ANZAC Research Institute, The University of Sydney, Sydney, New South Wales, Australia.
  • Nicholson GC; Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.
  • Duncan EL; Medical School, The University of Western Australia, Crawley, Western Australia, Australia.
  • Major G; Department of Endocrinology and Diabetes, Barwon Health, Geelong, Victoria, Australia.
  • Horne A; Rural Clinical School, University of Queensland, Toowoomba, Queensland, Australia.
  • Gilchrist NL; Department of Endocrinology and Diabetes, Royal Brisbane & Women's Hospital, Brisbane, Queensland, Australia.
  • Boers M; Faculty of Medicine, University of Queensland, Herston, Queensland, Australia.
  • Murray GD; Translational Genomics Group, Institute of Health and Biomedical Innovation, Faculty of Health, Queensland University of Technology, Woolloongabba, Queensland, Australia.
  • Charnock K; Royal Newcastle Centre John Hunter Hospital, University of Newcastle, Newcastle, New South Wales, Australia.
  • Wilkinson D; Department of Medicine, University of Auckland, Auckland, New Zealand.
  • Russell RGG; GCM Research Trust, Burnwood Hospital, Christchurch, New Zealand.
  • Ralston SH; Epidemiology & Biostatistics, Amsterdam Rheumatology and Immunology Center, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, Netherlands.
BMJ Open ; 9(9): e030689, 2019 09 04.
Article in En | MEDLINE | ID: mdl-31488492
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteitis Deformans / Bone Density Conservation Agents / Sequestosome-1 Protein / Zoledronic Acid Type of study: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies Limits: Adult / Humans Language: En Journal: BMJ Open Year: 2019 Type: Article Affiliation country: United kingdom
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Osteitis Deformans / Bone Density Conservation Agents / Sequestosome-1 Protein / Zoledronic Acid Type of study: Clinical_trials / Etiology_studies / Guideline / Prognostic_studies Limits: Adult / Humans Language: En Journal: BMJ Open Year: 2019 Type: Article Affiliation country: United kingdom